Pathos
Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning pl
Discovery Tools (Healthcare)
📍 Chicago, IL
Current Valuation
$600M
as of 2024-Q4
PRIVATE
Pathos develops an AI-enabled drug discovery platform to reduce the medication development process. Its self-learning platform utilizes big data, technology, and artificial intelligence to identify targets, validate them, and establish their clinical efficacy.
Company Profile
Last Round
Series C — $62M (Oct 2024)
Fundraising Status
Series C · $62M · 1y 8mo ago
privateTotal raised $102M
Latest Funding Round
| Round | Amount | Date | Lead Investor | Post-Money |
|---|
| Series C | $62M | Oct 2024 | — | $600M |
MedicalBig DataArtificial IntelligenceBiotechnologyLife Science
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2024-Q4. Refreshed quarterly.